Breathe Well Live Well
|
Reportlinker Adds the Asthma, COPD & Allergic Rhinitis Market Outlook to 2015
SYS-CON Media (press release) 21, 2010 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Global sales of asthma, … |
View full post on asthma – Google News
|
Reportlinker Adds the Asthma, COPD & Allergic Rhinitis Market Outlook to 2015
PR Newswire (press release) 21, 2010 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Global sales of asthma, … |
View full post on asthma – Google News
|
India's Asthma Drug Market Will Exceed $400 Million in 2014
PR-USA.net (press release) Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that India's asthma drug … |
View full post on asthma – Google News
|
India's asthma market “to grow 10% a year”
Pharma Times India's asthma drug market is set to grow from a value of $246 million in 2009 to $403 million in 2014, representing an annual growth rate of 10%, … |
View full post on asthma – Google News
|
India's Asthma Drug Market Will Exceed $400 Million in 2014
PR Newswire (press release) According to the Emerging Markets report entitled Asthma in India, this growth will be fueled by improved access to medical care, a growing drug-treated … |
View full post on asthma – Google News
|
Research and Markets: Asthma/COPD Market Forecast – 10 Year Country …
Live-PR.com (press release) (c) 2007 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. … |
View full post on asthma – Google News
|
SOHM India Targets $600 Million Generic Drug Market for Asthma and Respiratory …
SYS-CON Media (press release) Allergic respiratory disorders, in particular asthma, have recorded abnormally high levels in India. Even though genetic predisposition is one of the main … |
View full post on asthma – Google News
|
SOHM India Targets $600 Million Generic Drug Market for Asthma and Respiratory …
MarketWatch (press release) Allergic respiratory disorders, in particular asthma, have recorded abnormally high levels in India. Even though genetic predisposition is one of the main … |
View full post on asthma – Google News
|
Biota Holdings targeting asthma market with flu drug
Australian Life Scientist Biota Holdingstoday commenced a 400-member trial in the US of its anti-viral drug BTA798 on sufferers of asthma who have contracted cold and flu. … HRV Phase II Trial Underway in Patients |
View full post on asthma – Google News